Provided by Tiger Fintech (Singapore) Pte. Ltd.

DiaMedica Therapeutics Inc.

4.04
-0.1300-3.12%
Volume:56.30K
Turnover:226.64K
Market Cap:173.14M
PE:-6.68
High:4.23
Open:4.13
Low:3.86
Close:4.17
Loading ...

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate

Simply Wall St.
·
16 Nov 2024

Lake Street Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC)

TIPRANKS
·
15 Nov 2024

Q3 2024 DiaMedica Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Nov 2024

DiaMedica Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

DiaMedica Therapeutics Q3 2024 GAAP EPS $(0.15), Inline

Benzinga
·
14 Nov 2024

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics Inc: Cash Runway Into Q3 2026

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics doses first patient in Phase 2 DM199 trial

TIPRANKS
·
14 Nov 2024

DiaMedica Therapeutics Inc - Top Line Data for Part 1a Expected in First Half of 2025

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of Dm199 in the Treatment of Preeclampsia

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia

Business Wire
·
14 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 Nov 2024

DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference

Business Wire
·
12 Nov 2024

DiaMedica Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Press Release: DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024

Dow Jones
·
06 Nov 2024

DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024

THOMSON REUTERS
·
06 Nov 2024